802 related articles for article (PubMed ID: 22377664)
1. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.
Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664
[TBL] [Abstract][Full Text] [Related]
2. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
[TBL] [Abstract][Full Text] [Related]
3. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
[TBL] [Abstract][Full Text] [Related]
4. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
5. Transfemoral implantation of Edwards Sapien XT aortic valve without previous valvuloplasty: role of 2D/3D transesophageal echocardiography.
García E; Almería C; Unzué L; Jiménez-Quevedo P; Cuadrado A; Macaya C
Catheter Cardiovasc Interv; 2014 Nov; 84(6):868-76. PubMed ID: 24482054
[TBL] [Abstract][Full Text] [Related]
6. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral valve-in-valve implantation for degenerated bioprosthetic aortic valves using the new balloon-expandable Edwards Sapien 3 valve.
Gonska B; Seeger J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):636-643. PubMed ID: 27142354
[TBL] [Abstract][Full Text] [Related]
8. Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation.
Bijuklic K; Hansen L; Witt J; Schofer J
Clin Res Cardiol; 2015 Jan; 104(1):92-3. PubMed ID: 25227426
[No Abstract] [Full Text] [Related]
9. 3D Assessment of Features Associated With Transvalvular Aortic Regurgitation After TAVR: A Real-Time 3D TEE Study.
Shibayama K; Mihara H; Jilaihawi H; Berdejo J; Harada K; Itabashi Y; Siegel R; Makkar RR; Shiota T
JACC Cardiovasc Imaging; 2016 Feb; 9(2):114-23. PubMed ID: 26777225
[TBL] [Abstract][Full Text] [Related]
10. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
[TBL] [Abstract][Full Text] [Related]
11. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
[TBL] [Abstract][Full Text] [Related]
12. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
[TBL] [Abstract][Full Text] [Related]
13. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
[TBL] [Abstract][Full Text] [Related]
14. Optimal prosthesis sizing in transcatheter aortic valve implantation by exclusive use of three-dimensional transoesophageal echocardiography.
Kretzschmar D; Lauten A; Goebel B; Doenst T; Poerner TC; Ferrari M; Figulla HR; Hamadanchi A
Clin Physiol Funct Imaging; 2016 Mar; 36(2):99-105. PubMed ID: 25316588
[TBL] [Abstract][Full Text] [Related]
15. Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve.
Blanke P; Pibarot P; Hahn R; Weissman N; Kodali S; Thourani V; Parvataneni R; Dvir D; Naoum C; Nørgaard BL; Douglas P; Jaber W; Khalique OK; Jilaihawi H; Mack M; Smith C; Leon M; Webb J; Leipsic J
JACC Cardiovasc Interv; 2017 Apr; 10(8):810-820. PubMed ID: 28427598
[TBL] [Abstract][Full Text] [Related]
16. Abnormal distortion of aortic corevalve bioprosthesis with suicide left ventricle, aortic insufficiency, and severe mitral regurgitation during transcatheter aortic valve replacement.
Leya F; Tuchek JM; Coats W
Catheter Cardiovasc Interv; 2016 Dec; 88(7):1181-1187. PubMed ID: 26945836
[TBL] [Abstract][Full Text] [Related]
17. Overestimation of paravalvular leak with Edwards SAPIEN 3 transcatheter aortic valve replacement.
Kobayashi T; Giri J; Vallabhajosyula P; Herrmann HC; Jagasia DH
JACC Cardiovasc Interv; 2015 Apr; 8(5):e69-71. PubMed ID: 25946455
[No Abstract] [Full Text] [Related]
18. Severe intraprosthetic regurgitation and valve embolization after transcatheter aortic valve implantation.
Ben-Dor I; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Feb; 81(2):392-6. PubMed ID: 22566389
[TBL] [Abstract][Full Text] [Related]
19. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement.
Martinez CA; O'Neill B; Singh V; O'Neill WW
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182
[TBL] [Abstract][Full Text] [Related]
20. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
